Skip to content
RDL
Network
Ekosistem
Uygulama değiştir
EN
Hakkımızda
SSS
Giriş yap
Başla
Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials — Aviv Ladanie (2017) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials
Shared by
John P A Ioannidis
Stanford University
Off-label treatments were not consistently better or worse than approved drug treatments in randomized trials
Article
2017
en
Authors
+3 more
AL
Aviv Ladanie
John P A Ioannidis
Stanford University
RS
Randall S. Stafford
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2014
The Transitive Property Across Randomized Controlled Trials: If B Is Better Than A, and C Is Better Than B, Will C Be Better Than A?
Ferrán Catalá-López
,
Brian Hutton
,
David Moher
Article
2013
Are randomized trials obsolete or more important than ever in the genomic era?
John P A Ioannidis
,
Muin J. Khoury
Article
2022
Indicators of questionable research practices were identified in 163,129 randomized controlled trials
Johanna AAG Damen
,
Pauline Heus
,
Herm J. Lamberink
,
Joeri K. Tijdink
,
L.M. Bouter
,
Paul Glasziou
,
David Moher
,
Willem M. Otte
,
Christiaan H. Vinkers
,
Lotty Hooft
Article
2007
Reporting Methods of Blinding in Randomized Trials Assessing Nonpharmacological Treatments
Isabelle Boutron
,
Lydia Guittet
,
Candice Estellat
,
David Moher
,
Asbjørn Hróbjartsson
,
Philippe Ravaud
Article
2025
Trustworthiness and Transparency Features Were Less Frequent in Randomized Trials Presenting Large Effects in Abstracts
Jonathan Henssler
,
Joana Reis‐Pardal
,
Lina Koppel
,
John P A Ioannidis
Discussion(0)
No comments yet. Be the first to comment.